Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Accelerating Implementation of Long-Acting Injectables
The ALAI UP Project will support the implementation and delivery of LAI ART at eight demonstration sites in EHE jurisdictions across the US providing care to underserved populations and communities of color.RWHAP Technical Assistance Provider updated on 07/09/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Aging with HIV Initiative
SPNS project evaluating interventions that seek to improve the well-being of RWHAP clients 50 and older. Project period: 2022-2025.RWHAP Technical Assistance Provider updated on 02/27/2024
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
The Future of Trauma-Informed Care
As trauma awareness grows in all aspects of our communities, it is time to ask, “What are the next innovations in helping those with HIV recover from trauma?” This workshop will show how new technology helps to quantify resiliency and post-traumatic growth for patients and clients.
Resource (Conference Presentation) updated 09/14/2023
-
To Hell and Back: Rethinking Self-care
Before the pandemic, HIV providers were among the most burnt-out professions in our society. This workshop helps to identify the dangers to our mental, physical, and social health resulting from the demands our work combined with the exposure to the stress and trauma of our those we serve.
Resource (Conference Presentation) updated 09/14/2023
-
The Relationship Between Community and Interpersonal Violence, and HIV Prevalence Among Black women in Dallas, Texas
HIV prevalence among Black women is at epidemic levels with violence greatly contributing to this statistic. The application of machine learning to HIV studies has the ability to inform more personalized approaches to decreasing HIV prevalence as well as improve the health outcomes of those people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Plenary: Innovation (Ending the HIV Epidemic, National HIV/AIDS Strategy)
Applying the HIV/AIDS Bureau implementation science framework; trauma-informed care in dental settings; and review of an organization's status-neutral approach to care .
Resource (Conference Presentation) updated 09/14/2023
-
301: Strategies to Address IPV and Provide Trauma-informed Care for Black Cis and Transgender Women
Review of the RWHAP SPNS initiative Improving Care and Treatment Coordination for Black Women with HIV, which implements evidence-informed interventions to provide culturally relevant care for Black cis and transgender women.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
RWHAP Part B Supplemental PTR Manual
Instructions on how (RWHAP Part B Supplemental recipients can access, complete, and submit the RWHAP Part B Supplemental Program Terms Report (PTR).Resource updated 06/27/2024
-
Non-Competing Continuation RWHAP Part B/ADAP (X07): FY24 NCC Progress Report Submission
Instructions and resources for completing and submitting the FY 2024 Ryan White HIV/AIDS Program (RWHAP) Part B Non-Competing Continuation Progress Report.Resource updated 10/10/2023
-
Enhancing HIV Care of Women, Infants, Children and Youth: Building Capacity through Communities of Practice
Platform for RWHAP Part D recipients to increase the delivery of care innovations; increase the skills of staffing working with women, infant, children and youth; and support partner collaboration for dissemination of best practices.RWHAP Technical Assistance Provider updated on 05/24/2024
-
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023